However, Meisel et al. [115] recently described four patients with autoimmune-polyendocrine-syndrome type 1, and preexisting high levels of neutralizing antibodies against IFN-α and IFN-ω were associated with only mild symptoms of COVID-19. Here, IFNA1 is linked to COVID-19.